Methylation-dependent Silencing of the Reduced Folate Carrier Gene in Inherently Methotrexate-resistant Human Breast Cancer Cells
Open Access
- 1 October 2001
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 276 (43), 39990-40000
- https://doi.org/10.1074/jbc.m103181200
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Down-Regulation of Reduced Folate Carrier Gene (RFC1) Expression after Exposure to Methotrexate in ZR-75-1 Breast Cancer CellsBiochemical and Biophysical Research Communications, 2000
- CARRIER-MEDIATED MEMBRANE TRANSPORT OF FOLATES IN MAMMALIAN CELLSAnnual Review of Nutrition, 1999
- MRP3, an organic anion transporter able to transport anti-cancer drugsProceedings of the National Academy of Sciences, 1999
- A Structurally Altered Human Reduced Folate Carrier with Increased Folic Acid Transport Mediates a Novel Mechanism of Antifolate ResistancePublished by Elsevier BV ,1998
- A Reduced Folate Carrier Mutation Produces Substrate-dependent Alterations in Carrier Mobility in Murine Leukemia Cells and Methotrexate Resistance with Conservation of Growth in 5-FormyltetrahydrofolateJournal of Biological Chemistry, 1998
- Methotrexate Transport and ResistanceLeukemia & Lymphoma, 1998
- Intrinsic and Acquired Resistance to Methotrexate in Acute LeukemiaNew England Journal of Medicine, 1996
- Karnofsky memorial lecture. Ode to methotrexate.Journal of Clinical Oncology, 1993
- Mutant Chinese hamster ovary cells with defective methotrexate uptake are distinguishable by reversion analysisSomatic Cell and Molecular Genetics, 1989
- The Pharmacology and Clinical Use of MethotrexateNew England Journal of Medicine, 1983